Joshua Smiley
Präsident bei ZAI LAB LIMITED
Vermögen: 59 291 $ am 31.05.2024
Profil
Derzeit ist Joshua L. Smiley Treasurer, Director & Vice President bei CoLucid Pharmaceuticals, Inc. Herr Smiley ist außerdem im Vorstand der Butler University und der Eskenazi Health Foundation. In seiner früheren Karriere war er Chief Financial Officer & Senior Vice President bei Eli Lilly & Co. und Chief Financial Officer, Controller & SVP-Finance bei Lilly Research Laboratories (einer Tochtergesellschaft von Eli Lilly & Co.). Joshua L. Smiley erwarb einen Bachelor-Abschluss an der Harvard University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ZAI LAB LTD.
0,00% | 13.05.2024 | 31 684 ( 0,00% ) | 59 291 $ | 31.05.2024 |
Aktive Positionen von Joshua Smiley
Unternehmen | Position | Beginn |
---|---|---|
ZAI LAB LIMITED | Präsident | - |
Butler University | Direktor/Vorstandsmitglied | - |
Eskenazi Health Foundation | Direktor/Vorstandsmitglied | - |
Unseen Capital LLC
Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Berater | - |
Ehemalige bekannte Positionen von Joshua Smiley
Unternehmen | Position | Ende |
---|---|---|
ELI LILLY AND COMPANY | Finanzdirektor/CFO | 09.02.2021 |
ELANCO ANIMAL HEALTH INCORPORATED | Direktor/Vorstandsmitglied | 11.03.2019 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Finanzdirektor/CFO | 01.01.2015 |
COLUCID PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | - |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Joshua Smiley
Harvard University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
ZAI LAB LIMITED | Health Technology |
Private Unternehmen | 5 |
---|---|
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Eskenazi Health Foundation | |
Unseen Capital LLC
Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Finance |